Morphic Holding, Inc. (MORF)
Largest Insider Buys in Sector
MORF Stock Price History Chart
MORF Stock Performance
About Morphic Holding, Inc.
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and preclinical trial to treat idiopathic pulmonary fibrosis and fibrosis diseases. The company is also developing avß6 for the treatment of fibrotic diseases, and avß8 to treat solid tumors, as well as various other products. Morphic Holding, Inc. has a research collaboration with Engitix Ltd for the identification of Morphic integrin technology amenable targets in fibrostenotic IBD; a collaboration agreement with Schrödinger, LLC for integrin targets; and a license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. It also has collaboration agreements with AbbVie Biotechnology Ltd and Janssen Pharmaceuticals, Inc. to discover or develop integrin-based therapeutics. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Insider Activity of Morphic Holding, Inc.
Over the last 12 months, insiders at Morphic Holding, Inc. have bought $98,239 and sold $2.48M worth of Morphic Holding, Inc. stock.
On average, over the past 5 years, insiders at Morphic Holding, Inc. have bought $25.67M and sold $20.34M worth of stock each year.
Highest buying activity among insiders over the last 12 months: SLATTERY JOSEPH P (director) — $148,307. Edwards Martin (director) — $97,606.
The last purchase of 2,376 shares for transaction amount of $48,803 was made by Edwards Martin (director) on 2023‑11‑13.
List of Insider Buy and Sell Transactions, Morphic Holding, Inc.
| 2024-01-16 | Sale | Rogers Bruce | President | 6,314 0.0125% | $27.49 | $173,576 | +10.26% | |
| 2024-01-16 | Sale | Tipirneni Praveen P. | CEO | 13,923 0.0276% | $27.49 | $382,753 | +10.26% | |
| 2024-01-16 | Sale | SCHEGERIN MARC | CFO and COO | 6,041 0.012% | $27.49 | $166,071 | +10.26% | |
| 2024-01-16 | Sale | Farrell Robert E Jr | SVP Finance and CAO | 5,089 0.0101% | $27.49 | $139,900 | +10.26% | |
| 2024-01-16 | Sale | DeVaul William | General Counsel and Secretary | 4,509 0.0089% | $27.49 | $123,956 | +10.26% | |
| 2023-11-13 | SLATTERY JOSEPH P | director | 2,400 0.0048% | $20.60 | $49,436 | +41.82% | ||
| 2023-11-13 | Edwards Martin | director | 2,376 0.0047% | $20.54 | $48,803 | +41.82% | ||
| 2023-09-07 | Sale | SCHEGERIN MARC | CFO and COO | 20,000 0.0423% | $54.34 | $1.09M | -46.01% | |
| 2023-08-01 | Sale | Tipirneni Praveen P. | President and CEO | 3,597 0.0081% | $57.04 | $205,187 | -48.75% | |
| 2023-07-03 | Sale | Tipirneni Praveen P. | President and CEO | 3,597 0.009% | $57.04 | $205,178 | -47.15% | |
| 2023-06-12 | Sale | Tipirneni Praveen P. | President and CEO | 840 0.0022% | $63.01 | $52,929 | -49.90% | |
| 2023-06-07 | Sale | DeVaul William | General Counsel and Secretary | 7,756 0.0189% | $60.05 | $465,742 | -50.02% | |
| 2023-06-01 | Sale | Tipirneni Praveen P. | President and CEO | 3,597 0.0091% | $57.14 | $205,519 | -45.21% | |
| 2023-05-24 | Sale | DeVaul William | General Counsel and Secretary | 100 0.0003% | $60.00 | $6,000 | -45.85% | |
| 2023-05-23 | Sale | Farrell Robert E Jr | SVP Finance and CAO | 10,000 0.0251% | $60.00 | $600,000 | -45.97% | |
| 2023-05-23 | Sale | DeVaul William | General Counsel and Secretary | 3,802 0.0096% | $60.03 | $228,236 | -45.97% | |
| 2023-05-03 | Sale | Tipirneni Praveen P. | President and CEO | 3,597 0.009% | $51.11 | $183,857 | -32.25% | |
| 2023-05-03 | SPRINGER TIMOTHY A | 1.05M 2.3011% | $45.00 | $47.25M | -32.25% | |||
| 2023-04-25 | Sale | Rogers Bruce | President | 30,000 0.0855% | $53.40 | $1.6M | -23.66% | |
| 2023-04-25 | Sale | SCHEGERIN MARC | CFO and COO | 50,000 0.146% | $54.71 | $2.74M | -23.66% |
Insider Historical Profitability
| Rogers Bruce | President | 142036 0.2855% | $32.46 | 0 | 18 | |
| Tipirneni Praveen P. | CEO | 42013 0.0845% | $32.46 | 0 | 28 | |
| SCHEGERIN MARC | CFO and COO | 37460 0.0753% | $32.46 | 1 | 10 | <0.0001% |
| Farrell Robert E Jr | SVP Finance and CAO | 34992 0.0703% | $32.46 | 0 | 31 | |
| DeVaul William | General Counsel and Secretary | 23029 0.0463% | $32.46 | 0 | 18 | |
| SLATTERY JOSEPH P | director | 9066 0.0182% | $32.46 | 2 | 0 | <0.0001% |
| Edwards Martin | director | 2376 0.0048% | $32.46 | 1 | 0 | |
| Stampacchia Otello | 2969582 5.9698% | $32.46 | 1 | 0 | <0.0001% | |
| SPRINGER TIMOTHY A | 2768464 5.5655% | $32.46 | 10 | 0 | <0.0001% | |
| Novo Holdings A/S | 10 percent owner | 2645446 5.3182% | $32.46 | 1 | 0 | <0.0001% |
| GLAXOSMITHKLINE PLC | director | 2633772 5.2948% | $32.46 | 1 | 0 | <0.0001% |
| Omega Fund V, L.P. | director | 2068913 4.1592% | $32.46 | 1 | 78 | <0.0001% |
| Nashat Amir | director | 136691 0.2748% | $32.46 | 1 | 1 | <0.0001% |
| Lugovskoy Alexey | Chief Development Officer | 85248 0.1714% | $32.46 | 0 | 19 | |
| Linde Peter | Chief Medical Officer | 11272 0.0227% | $32.46 | 0 | 3 | |
| Goyal Vikas | director | 1000 0.002% | $32.46 | 2 | 0 | <0.0001% |
Institutional Investor Ownership
| Fidelity Investments | $264.2M | 14.98 | 7.51M | +10.65% | +$25.42M | 0.02 | |
| Point72 Asset Management | $164.99M | 9.36 | 4.69M | +2.09% | +$3.38M | 0.31 | |
| Wellington Management Company | $141.61M | 8.03 | 4.02M | +19.12% | +$22.73M | 0.02 | |
| BlackRock | $115.57M | 6.55 | 3.28M | -0.59% | -$681,542.41 | <0.01 | |
| State Street | $93.83M | 5.32 | 2.67M | +3.96% | +$3.57M | <0.01 | |
| T. Rowe Price | $88.83M | 5.04 | 2.52M | +13.54% | +$10.59M | 0.01 | |
| Ecor1 Capital Llc | $83.93M | 4.76 | 2.38M | +1,028.64% | +$76.49M | 2.13 | |
| The Vanguard Group | $79.59M | 4.51 | 2.26M | -2.58% | -$2.11M | <0.01 | |
| Artal Group S A | $77.9M | 4.42 | 2.21M | +3.51% | +$2.64M | 0.41 | |
| Federated Hermes | $35.02M | 1.99 | 995,000 | -0.5% | -$176,000.00 | 0.08 | |
| Geode Capital Management | $31.52M | 1.79 | 895,200 | +4.94% | +$1.48M | <0.01 | |
| Citadel Advisors LLC | $30.51M | 1.73 | 866,898 | +737.28% | +$26.87M | 0.02 | |
| OrbiMed | $19.66M | 1.12 | 558,500 | +104.28% | +$10.04M | 0.4 | |
| Goldman Sachs | $19.15M | 1.09 | 543,945 | -14.35% | -$3.21M | <0.01 | |
| Silverarc Capital Management Llc | $17.04M | 0.97 | 483,972 | -3.21% | -$565,663.99 | 5.02 | |
| Two Sigma Advisers LP | $13.56M | 0.77 | 385,100 | -30.63% | -$5.98M | 0.02 | |
| Northern Trust | $11.94M | 0.68 | 339,310 | -1.34% | -$162,377.60 | <0.01 | |
| Charles Schwab | $11.5M | 0.65 | 326,697 | +2.27% | +$255,094.39 | <0.01 | |
| Bioimpact Capital Llc | $11.45M | 0.65 | 325,333 | +0.49% | +$56,003.20 | 1.85 | |
| Perceptive Advisors | $10.15M | 0.58 | 288,221 | +405.83% | +$8.14M | 0.01 | |
| Two Sigma | $9.04M | 0.51 | 256,751 | -46.16% | -$7.75M | 0.02 | |
| Candriam S C A | $8.8M | 0.5 | 249,933 | 0% | +$0 | 0.06 | |
| DAFNA Capital Management, LLC | $8.16M | 0.46 | 231,748 | 0% | +$0 | 1.9 | |
| Affinity Asset Advisors | $7.92M | 0.45 | 225,000 | +427.3% | +$6.42M | 1.41 | |
| Rafferty Asset Management Llc | $7.77M | 0.44 | 220,794 | +8.91% | +$635,993.62 | 0.02 | |
| Dimensional Fund Advisors | $7.78M | 0.44 | 221,162 | -5.98% | -$495,052.71 | <0.01 | |
| Morgan Stanley | $7.76M | 0.44 | 220,575 | -68.31% | -$16.73M | <0.01 | |
| Fiduciary Trust Co | $7.55M | 0.43 | 214,366 | 0% | +$0 | 0.12 | |
| D. E. Shaw & Co. | $7.55M | 0.43 | 214,456 | -28.96% | -$3.08M | 0.01 | |
| T Rowe Price Investment Management Inc | $6.91M | 0.39 | 196,225 | +20.13% | +$1.16M | <0.01 | |
| Citigroup | $6.7M | 0.38 | 190,345 | +117.95% | +$3.63M | 0.01 | |
| Omega Fund Management Llc | $5.63M | 0.32 | 159,846 | -48.41% | -$5.28M | 4.17 | |
| Balyasny Asset Management Llc | $5.25M | 0.3 | 149,253 | +741.72% | +$4.63M | 0.01 | |
| UBS | $5.24M | 0.3 | 148,994 | +60.98% | +$1.99M | <0.01 | |
| Ensign Peak Advisors Inc | $4.97M | 0.28 | 141,223 | -38.58% | -$3.12M | 0.01 | |
| Nuveen | $4.46M | 0.25 | 126,702 | +0.24% | +$10,912.00 | <0.01 | |
| Td Asset Management Inc | $4.43M | 0.25 | 125,900 | +41.91% | +$1.31M | <0.01 | |
| BNY Mellon | $4.4M | 0.25 | 124,894 | -3.66% | -$166,988.77 | <0.01 | |
| Bank of America | $4.03M | 0.23 | 114,562 | -59.71% | -$5.98M | <0.0001 | |
| Prudential Financial | $4M | 0.23 | 113,627 | -40.68% | -$2.74M | 0.01 | |
| AllianceBernstein | $3.93M | 0.22 | 111,782 | -46.56% | -$3.43M | <0.01 | |
| Connor Clark & Lunn Investment Management Ltd | $3.68M | 0.21 | 104,630 | +208.94% | +$2.49M | 0.01 | |
| Woodline Partners LP | $3.52M | 0.2 | 100,000 | New | +$3.52M | 0.03 | |
| Allianz Asset Management Gmbh | $3.3M | 0.19 | 93,670 | +12.2% | +$358,441.60 | 0.01 | |
| Atom Investors Lp | $3.05M | 0.17 | 86,630 | +17.53% | +$454,889.60 | 0.38 | |
| Saturn V Capital Management Llc | $3.01M | 0.17 | 85,632 | -59.67% | -$4.46M | 1.21 | |
| The Manufacturers Life Insurance Company | $2.88M | 0.16 | 81,945 | +36.64% | +$773,449.60 | <0.01 | |
| Assenagon Asset Management S.A. | $2.51M | 0.14 | 71,384 | -26.73% | -$916,537.67 | 0.01 | |
| Susquehanna International Group | $2.46M | 0.14 | 69,899 | +388.22% | +$1.96M | <0.01 | |
| Alger | $2.26M | 0.13 | 64,195 | -2.21% | -$51,180.80 | 0.01 |